These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15261294)

  • 1. Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.
    Sharma V; Tepe JJ
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4319-21. PubMed ID: 15261294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotection by hymenialdisine-derived checkpoint kinase 2 inhibitors.
    Nguyen TN; Saleem RS; Luderer MJ; Hovde S; Henry RW; Tepe JJ
    ACS Chem Biol; 2012 Jan; 7(1):172-84. PubMed ID: 22004065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors.
    Saleem RS; Lansdell TA; Tepe JJ
    Bioorg Med Chem; 2012 Feb; 20(4):1475-81. PubMed ID: 22285028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytokine production by hymenialdisine derivatives.
    Sharma V; Lansdell TA; Jin G; Tepe JJ
    J Med Chem; 2004 Jul; 47(14):3700-3. PubMed ID: 15214798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and target identification of hymenialdisine analogs.
    Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
    Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1).
    Tasdemir D; Mallon R; Greenstein M; Feldberg LR; Kim SC; Collins K; Wojciechowicz D; Mangalindan GC; Concepción GP; Harper MK; Ireland CM
    J Med Chem; 2002 Jan; 45(2):529-32. PubMed ID: 11784156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
    Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
    J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.
    Meijer L; Thunnissen AM; White AW; Garnier M; Nikolic M; Tsai LH; Walter J; Cleverley KE; Salinas PC; Wu YZ; Biernat J; Mandelkow EM; Kim SH; Pettit GR
    Chem Biol; 2000 Jan; 7(1):51-63. PubMed ID: 10662688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine.
    Curman D; Cinel B; Williams DE; Rundle N; Block WD; Goodarzi AA; Hutchins JR; Clarke PR; Zhou BB; Lees-Miller SP; Andersen RJ; Roberge M
    J Biol Chem; 2001 May; 276(21):17914-9. PubMed ID: 11279124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new glycociamidine ring precursor: syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (+/-)-endo-2-debromohymenialdisine.
    Papeo G; Posteri H; Borghi D; Varasi M
    Org Lett; 2005 Dec; 7(25):5641-4. PubMed ID: 16321011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
    White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
    Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB.
    Breton JJ; Chabot-Fletcher MC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):459-66. PubMed ID: 9223588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors.
    Nguyen TN; Tepe JJ
    Curr Med Chem; 2009; 16(24):3122-43. PubMed ID: 19689287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
    Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
    J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
    Zhang N; Zhong R; Yan H; Jiang Y
    Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.
    Xie J; Tian J; Su L; Huang M; Zhu X; Ye F; Wan Y
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4306-9. PubMed ID: 21696953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore.
    Stevenson CS; Capper EA; Roshak AK; Marquez B; Eichman C; Jackson JR; Mattern M; Gerwick WH; Jacobs RS; Marshall LA
    J Pharmacol Exp Ther; 2002 Nov; 303(2):858-66. PubMed ID: 12388673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
    Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor.
    Lountos GT; Tropea JE; Zhang D; Jobson AG; Pommier Y; Shoemaker RH; Waugh DS
    Protein Sci; 2009 Jan; 18(1):92-100. PubMed ID: 19177354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.
    Stukenbrock H; Mussmann R; Geese M; Ferandin Y; Lozach O; Lemcke T; Kegel S; Lomow A; Burk U; Dohrmann C; Meijer L; Austen M; Kunick C
    J Med Chem; 2008 Apr; 51(7):2196-207. PubMed ID: 18345612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.